Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

Human monoclonal antibodies (HMAbs) with neutralizing capabilities constitute potential immune-based treatments or prophylaxis against hepatitis C virus (HCV). However, lack of cell culture-derived HCV (HCVcc) harboring authentic envelope proteins (E1/E2) has hindered neutralization investigations a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepatology
Egile Nagusiak: Carlsen, Thomas H.R., Pedersen, Jannie, Prentoe, Jannick C., Giang, Erick, Keck, Zhen-Yong, Mikkelsen, Lotte S., Law, Mansun, Foung, Steven K. H., Bukh, Jens
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4415877/
https://ncbi.nlm.nih.gov/pubmed/25043937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27298
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak